William W. Turner, JR.,Leping Li,Simon Nicolas Haydar,Mark G. Bures,Roopa Rai,Samson Francis,Lee D. Arnold
申请号：
US16490223
公开号：
US20200157070A1
申请日:
2018.03.01
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful as modulators of Hepatitis B (HBV) core protein, and methods of treating Hepatitis B (HBV) infection.
